{"name":"Lux Biosciences, Inc.","slug":"lux-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LX211","genericName":"LX211","slug":"lx211","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"LX211","genericName":"LX211","slug":"lx211","phase":"phase_3","mechanism":"LX211 is an investigational therapeutic in phase 3 development by Lux Biosciences with an undisclosed mechanism of action.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNbFpTTFRyb1lXTDA4R2pkZmEwMmxwY1QyTTBDOUFzSlBwSVRLY2NSVEotcnRha3haVHFDMzdNZmwyamFQRnU4MW1JUUNSZ3lLelMyNTNGZVJMMC1MNEktNlFBQ2VlNGlUYU1nR0VaUFBLMVlFb2tSSFg2UzV5QnpkdnNhVEQ2NWNMbm11LVBJc01PVjRFamtvenItZkFnc2No?oc=5","date":"2026-04-03","type":"deal","source":"The Next Web","summary":"Anthropic acquires biotech AI startup Coefficient Bio for $400 million - The Next Web","headline":"Anthropic acquires biotech AI startup Coefficient Bio for $400 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-18","type":"pipeline","source":"GlobeNewswire","summary":"Atavistik Bio Raises $120 Million Series B Financing to - GlobeNewswire","headline":"Atavistik Bio Raises $120 Million Series B Financing to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNTEg5YUdING5NelQzQTQtUDg3VmpJMWsxRnBpZ0NqM2VOOFlSa3Ntc3VEbXN4YTRHUXBQTzBBS1F6VXBRSE9KRENLdGxVU2xrMXlIckJldnNrdEFCZ1haamswaEZfc1BJX0RFcHBrekUxdGNtZEY3Qlg3ZVQ2cThlUGQ5UjVkYkhNT1VjZzFTN01PY0hNRWkzX213MlVfMXpQR1V4YlBRbDk5ZDdIM0E?oc=5","date":"2025-10-24","type":"pipeline","source":"Bloomberg.com","summary":"OpenAI Backs a New Venture Trying to Thwart AI Bio-Attacks - Bloomberg.com","headline":"OpenAI Backs a New Venture Trying to Thwart AI Bio-Attacks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPLTRoemFGeUh4b1RmYXV6WFFCWXhNMWNJQ3BxYXZ3RkJtejdQWjZ4elRUZ0RDaXBrNU5OZGQ2MjdqU25hbzlIMUJ0ZjlYbmNpZkJYcjJwYUFTa3c0cl8tX21VaFB6RVlZbThWcVNPUEZWVFpjTXFzU0JIUWhtc3dfdXdVdWNLelBGMDhMZURzV1lmZGNvZ2NBR0k3eHUzeVk?oc=5","date":"2025-10-08","type":"pipeline","source":"BioPharma Dive","summary":"Venture firms pour $101M into a biotech using the brain to fix the immune system - BioPharma Dive","headline":"Venture firms pour $101M into a biotech using the brain to fix the immune system","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNdlBkaTJXdGNDcENYMHFQUnFOS2JNLVVmNlBuZmJDTkgyLWItblhfbV9zVDVMcTVmc3YtNVVyNnFoekthYk5Wam5TcmpVY3hoVlVySlFWR3JCWFgteGp4dm9ERk43TmloZy1jUS1mUjU0X0QxTktSVHBMbUVSa3Rfckx6Z2hqcm43WDk1ejdmbUZWODJtX0oyd1dJb2xLOUdQaDhRS0t6dWNLTXhrdnkzaGoyNkRicE5Z?oc=5","date":"2025-10-08","type":"pipeline","source":"MedCity News","summary":"Startup Nilo Launches With $101M for Autoimmune Drugs That Target ‘Brain-Body Circuits’ - MedCity News","headline":"Startup Nilo Launches With $101M for Autoimmune Drugs That Target ‘Brain-Body Circuits’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxQc3pWYl9rSHBVa2lXU3FuMGF3b0hiYXdGMzY1VlZueFJsc0NkNjJiYnJfbUtsakxMU1RDN2dFR2FFYXA3NUhmc1NIU1VCZEYzQm56eDNCSTM1dFFsM1d2SHh2d1pYS3I1N0t5Q3pxbmpzU1dpSlpKcnhRNm10bGhoN2dtYkZwWEtDSkl2TjBwWm9pV0YyZHNxdVpNSVlZaGxPUlByblZRNWltd0RLVmFLc2x4VS05VzZYMElwcm96VHRCaGMzZUIwQ3JHbWU2SWpaSHNkQUVEeXF2aHBnRFJoOHdZdTByaC05NjlSbjlYNFI0MlcwNnpqYVhuNXhhTHV0b1NoaFRNbjhRRnJ1ZzFPbmkzaHhORUtXTlNja3J1S0Y0c0Qzanhoa2h3SzFtYnNxZWxTaF9xUzBvdmc?oc=5","date":"2025-02-19","type":"pipeline","source":"GlobeNewswire","summary":"Atrandi Biosciences Raises $25M Series A Led by Lux Capital - GlobeNewswire","headline":"Atrandi Biosciences Raises $25M Series A Led by Lux Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQMmIzcU9WUTVqR1VLRTZPSUlNRTdraTl2RDVJZ3BKbDdtNGs0YWlfRXZ4a2lGd0RjSFczWEdUQUg4MHRjTXpLWW5XRWxFTDRHdUdjQXNQTnl6cDloQ1F5OEpuNl82blAyX2ZXNTh6SC0xc09sTlF4czVaTmxIazBCaVRlRzdaZw?oc=5","date":"2024-03-19","type":"pipeline","source":"bioprocessonline.com","summary":"Eying Up The ERA Of Topical Biologics - bioprocessonline.com","headline":"Eying Up The ERA Of Topical Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5Udm8tRkU0UHV1VG1jRk16TGdGTEl3WUp4X1hBZnRmbjA0SEZVTjNtbnkzWWpMU2hfU19GX09Oel9aMnE2TzRjSTdrZVlNbUdVUHpRdWRBVWViTktTSHJRQTJ1eWVqYnBkeUtPbm9B?oc=5","date":"2023-10-25","type":"pipeline","source":"KED Global","summary":"Medytox to enter China’s botulinum toxin market with Newlux - KED Global","headline":"Medytox to enter China’s botulinum toxin market with Newlux","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNX0lzQl93VDZvM092Q1Mxd0wwU195RnZRV1VlWFktbVpvLTJPVXBCVk9tQTh0V19ZTEhxR3Q0MVBGRVlyNmMyNXdyMEtSeVMybUNzcFU3bUp0dlpEeUs3b3FyZ1ZaSU5KV0MxNzMzTTBKUGU1blFCdEdhTl92Ni01QlBFSmY2LThGXy1SYWVmM05JRFMtdml6SkxBQnFFYUhMZ2VMTUhQeEFfanc?oc=5","date":"2023-10-03","type":"pipeline","source":"dicardiology.com","summary":"Boston Scientific launches LUX-Dx II+ Insertable Cardiac Monitor System - dicardiology.com","headline":"Boston Scientific launches LUX-Dx II+ Insertable Cardiac Monitor System","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOa3B4MVV4X3I2bzA2VF9UY09xcklVNVFHMVhKVGtJRHVWRE0wN1Q5eGtpbmVQcmVBaXdsWnF1RG96OXYwQ2ZQSUZCNXFHeGZGR2ZKbVItZ1hMRTJiTnZIY1FYVTNvejhOUHpETkVrVXVDWGQzVVN6OEtWaG5DQk16V2NlWXV4TjBNdDF5R1U3b2QxYjc1bVVjZkVqRTJCQUJmLVkzalhvN1R5SVNCRE93OXc2ZVU4b2kxQ1BtNkdfdkZfeVdMUUE?oc=5","date":"2021-06-22","type":"pipeline","source":"Business Wire","summary":"Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital - Business Wire","headline":"Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdkgtbXZRUlNzdU9HckNkVUJobkRuYm10MlhENkRsZkoyNXRYX0lVLVR0emhjMV83c3ZuUmhsNkdOLTdtRVhDSWJSeE82ZWQwZkFaQ1BGcWRqZEs0cWxDTC0zUmxiZEJMdnVJdVpFMUNST0hFQS1iRFhNX0JpZGVfQTVTbHVGT0hKaUF6Rm82Ykd2Zm1PdjF4OGhrU2pVa19hbnpOZF9CU19EbVk?oc=5","date":"2018-10-17","type":"pipeline","source":"newswire.com","summary":"Advanced Bio-Oil Technologies Limited Forging Ahead: Bio-Oils for the Cosmetic, Pharmaceutical and Biofuel Industry, Regulation A+, Company Milestones and a Note From the CEO - newswire.com","headline":"Advanced Bio-Oil Technologies Limited Forging Ahead: Bio-Oils for the Cosmetic, Pharmaceutical and Biofuel Industry, Reg","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}